KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Inventory Average (2016 - 2025)

Sarepta Therapeutics has reported Inventory Average over the past 10 years, most recently at $996.0 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 51.37% year-over-year to $996.0 million; the TTM value through Dec 2025 reached $996.0 million, up 51.37%, while the annual FY2025 figure was $832.4 million, 55.17% up from the prior year.
  • Inventory Average for Q4 2025 was $996.0 million at Sarepta Therapeutics, down from $1.0 billion in the prior quarter.
  • Over five years, Inventory Average peaked at $1.0 billion in Q3 2025 and troughed at $192.6 million in Q1 2022.
  • A 5-year average of $428.7 million and a median of $266.6 million in 2021 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: decreased 22.96% in 2022 and later surged 142.88% in 2025.
  • Year by year, Inventory Average stood at $237.3 million in 2021, then fell by 10.43% to $212.6 million in 2022, then soared by 33.33% to $283.4 million in 2023, then surged by 132.13% to $657.9 million in 2024, then surged by 51.37% to $996.0 million in 2025.
  • Business Quant data shows Inventory Average for SRPT at $996.0 million in Q4 2025, $1.0 billion in Q3 2025, and $967.7 million in Q2 2025.